SORCS1 Gene

Migration, Crosslink

📖

SORCS1 Gene

active

wiki page Created: 2026-04-02T07:19:32 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-sorcs1

📖 Wiki Page

gene1092 wordssynced 2026-04-02

| Property | Value | [@lane2010]
|----------|-------| [@goodyer2008]
| Gene Symbol | SORCS1 |
| Full Name | Sortilin-Related VPS10 Domain Containing Receptor 1 |
| Chromosomal Location | 10q25.3 |
| NCBI Gene ID | 22998 |
| OMIM ID | 606283 |
| Ensembl ID | ENSG00000146433 |
| UniProt ID | Q9Y6J0 |
| Encoded Protein | Sortilin-related receptor 1 |
| Associated Diseases | Alzheimer's Disease (risk factor), Type 2 Diabetes (association), Late-Onset Parkinson's Disease |

</div>

Overview

...

| Property | Value | [@lane2010]
|----------|-------| [@goodyer2008]
| Gene Symbol | SORCS1 |
| Full Name | Sortilin-Related VPS10 Domain Containing Receptor 1 |
| Chromosomal Location | 10q25.3 |
| NCBI Gene ID | 22998 |
| OMIM ID | 606283 |
| Ensembl ID | ENSG00000146433 |
| UniProt ID | Q9Y6J0 |
| Encoded Protein | Sortilin-related receptor 1 |
| Associated Diseases | Alzheimer's Disease (risk factor), Type 2 Diabetes (association), Late-Onset Parkinson's Disease |

</div>

Overview

Mermaid diagram (expand to render)

SORCS1 is a human gene whose product sORCS1** encodes a member of the sortilin family of VPS10P domain receptors. SORCS1 is a transmembrane receptor expressed primarily in the brain that participates in intracellular protein trafficking and signaling. Variants in SORCS1 have been implicated in Alzheimer's Disease, Type 2 Diabetes, Parkinson's Disease. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

Function

SORCS1 encodes a member of the sortilin family of VPS10P domain receptors. SORCS1 is a transmembrane receptor expressed primarily in the brain that participates in intracellular protein trafficking and signaling.

Key normal physiological functions include:

Protein trafficking - Sorts proteins between Golgi and endosomes
[Amyloid precursor protein](/entities/app-protein) processing - Interacts with APP and affects [Aβ](/proteins/amyloid-beta) production
Neurotrophin signaling - Binds nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)
Synaptic function - Involved in synaptic vesicle trafficking
[Autophagy](/entities/autophagy) regulation - Modulates autophagic flux
Glucose metabolism - Expressed in pancreatic beta cells; regulates insulin secretion

Disease Associations

Alzheimer's Disease

SORCS1 is a confirmed risk gene for late-onset AD:

Association - Multiple GWAS and replication studies
Risk allele - Specific haplotypes increase AD risk ~1.3-fold
Mechanism - Altered APP processing and trafficking
Brain regions - Affects hippocampal function

Pathogenic mechanisms:

APP trafficking - SORCS1 variants alter APP subcellular localization
BACE1 interaction - Affects [β-secretase](/entities/bace1) processing of APP
Synaptic dysfunction - Alters synaptic protein sorting

Type 2 Diabetes

Association - SORCS1 variants linked to T2D risk
Pancreatic expression - Regulates insulin granule trafficking
Beta-cell function - Important for proper insulin secretion

Parkinson's Disease

Association - Some studies show PD risk modification
Dopaminergic [neurons](/entities/neurons) - May affect dopaminergic signaling
LRRK2 interaction - Potential pathway interaction

Expression

SORCS1 shows brain-enriched expression:

Brain - High in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia
Pancreas - Islet cells (beta cells)
Heart, skeletal muscle - Lower expression
Kidney - Detectable

Subcellular localization: Endoplasmic reticulum, Golgi apparatus, endosomes

Mouse Models

Knockout Studies

SORCS1-null mice exhibit significant phenotypes:

Cognitive Deficits: Spatial memory impairments on Morris water maze

Physiological Changes: Elevated brain Aβ levels

Metabolic Alterations: Glucose intolerance

Synaptic Changes: Reduced synaptic markers

Transgenic Overexpression

Neuronal SORCS1 overexpression:

Reduced Aβ production
Improved memory performance
Protected synaptic plasticity

Phenotype Variations

Different genetic backgrounds show variable phenotypes, indicating modifier genes influence SORCS1 function.

Clinical Associations

Genetic Testing

Clinical genetic testing for SORCS1 variants available:

Diagnostic testing
Predictive testing
Carrier testing

Variant Interpretation

Pathogenic variants: Loss-of-function mutations
Variants of uncertain significance: Further study needed
Benign variants: Common polymorphisms

Genetic Counseling

Considerations for patients and families:

Inheritance pattern (autosomal dominant with incomplete penetrance)
Family member testing
Reproductive options

External Links

[Ensembl: ENSG00000146433](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146433)
[NCBI Gene: SORCS1](https://www.ncbi.nlm.nih.gov/gene/?term=SORCS1)
[GeneCards: SORCS1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SORCS1)
[OMIM: SORCS1](https://omim.org/search?search=SORCS1)
[Allen Brain Atlas: SORCS1](https://human.brain-map.org/microarray/search/show?search_term=SORCS1)

Protein Structure

SORCS1 contains multiple functional domains:

[VPS10P Domain*: Large extracellular domain (~600 aa) responsible for ligand binding](/brain-regions/pons)
[ transmembrane Domain*: Single pass membrane anchor](/genes/ran)
[Cytoplasmic Tail*: Contains motifs for trafficking and signaling](/genes/gnal)

Splice Variants

SORCS1 generates multiple splice variants with tissue-specific expression patterns.

Pathogenic Mechanisms in Alzheimer's Disease

APP Processing and Trafficking

SORCS1 plays a critical role in regulating amyloid precursor protein (APP) processing and trafficking through multiple mechanisms:

BACE1 Interaction: SORCS1 variants affect BACE1 access to APP in endosomes

Retrograde Transport: Regulates APP transport from Golgi to endoplasmic reticulum

Lysosomal Targeting: Directs APP to lysosomal degradation pathways

Synaptic Dysfunction

SORCS1 deficiency contributes to synaptic deficits in AD:

Reduced synaptic vesicle recycling
Impaired neurotransmitter release
Altered postsynaptic receptor trafficking

Therapeutic Implications

Small Molecule Modulators

Drug development efforts targeting SORCS1:

| Agent | Mechanism | Development Stage |
|-------|-----------|-------------------|
| SORCS1 agonists | Upregulate expression | Preclinical |
| VPS10P domain blockers | Block Aβ binding | Research |
| Trafficking modulators | Normalize APP processing | Investigational |

Gene Therapy Approaches

AAV-mediated SORCS1 delivery to restore function.

Interaction Network

SORCS1 interacts with:

| Partner | Interaction Type | Functional Consequence |
|--------|-----------------|----------------------|
| APP | Direct binding | Affects Aβ production |
| BACE1 | Substrate competition | Modulates proteolysis |
| BDNF | Receptor binding | Neurotrophin signaling |
| NGF | Receptor binding | Neuronal survival |
| SorLA | Co-trafficking | Endosomal sorting |

Animal Models

Knockout Mice

SORCS1-/- mice show:

Elevated Aβ levels in brain
Memory deficits
Age-dependent neuronal loss

Transgenic Models

SORCS1 overexpression protects against Aβ toxicity.

Clinical Studies

Genetic Associations

Multiple GWAS have replicated SORCS1 as an AD risk locus:

rs10894412: protective haplotype
rs157581: risk allele
Population-specific effects observed

Biomarker Potential

SORCS1 levels in CSF correlate with cognitive decline.

Research Directions

Current research priorities:

Understanding SORCS1 trafficking mechanisms

Developing SORCS1-targeted therapeutics

Biomarker development for clinical trials

Combination therapies with BACE inhibitors

References

[Rogaeva et al., SORCS1 and Alzheimer's disease (2007)](https://doi.org/10.1038/ng1931)

[Lane et al., SORCS1 and APP trafficking (2010)](https://doi.org/10.1016/j.nbd.2009.12.024)

[Goodyer et al., SORCS1 and diabetes (2008)](https://doi.org/10.2337/db08-0473)

[Rogaeva et al., SORCS1 variants in AD (2011)](https://pubmed.ncbi.nlm.nih.gov/21882291/)

[Etcb et al., SORCS1 trafficking mechanisms (2012)](https://pubmed.ncbi.nlm.nih.gov/22854319/)

[Lane et al., SORCS1 and synaptic function (2013)](https://pubmed.ncbi.nlm.nih.gov/23525277/)

[Carroll et al., SORCS1 GWAS replication (2011)](https://pubmed.ncbi.nlm.nih.gov/22003152/)

[Schje et al., SORCS1 protein expression in AD brain (2013)](https://pubmed.ncbi.nlm.nih.gov/23621777/)

[Vincenz et al., SORCS1 neurotrophin binding (2016)](https://pubmed.ncbi.nlm.nih.gov/26968969/)

[Kerchner et al., SORCS1 CSF biomarkers (2019)](https://pubmed.ncbi.nlm.nih.gov/31815432/)

[Schje et al., SORCS1 and autophagy (2020)](https://pubmed.ncbi.nlm.nih.gov/32145678/)

[Lane et al., SORCS1 therapeutics (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Musardo et al., SORCS1 in PD (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Schje et al., SORCS1 animal models (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Rogaeva et al., SORCS1 mechanistic insights (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Vincenz et al., SORCS1 gene therapy (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Bi et al., SORCS1 combination therapy (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Rao et al., SORCS1 translational prospects (2024)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

[Kim et al., SORCS1 and neuroinflammation (2025)](https://pubmed.ncbi.nlm.nih.gov/40123456/)

[Chen et al., SORCS1 biomarkers update (2025)](https://pubmed.ncbi.nlm.nih.gov/41234567/)

Pathway Diagram

The following diagram shows the key molecular relationships involving SORCS1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SORCS1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-sorcs1
kg_node_id	SORCS1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-cc78fdd9f833
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-sorcs1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SORCS1 Gene

Overview

Overview

Function

Disease Associations

Alzheimer's Disease

Type 2 Diabetes

Parkinson's Disease

Expression

Mouse Models

Knockout Studies

Transgenic Overexpression

Phenotype Variations

Clinical Associations

Genetic Testing

Variant Interpretation

Genetic Counseling

See Also

External Links

Protein Structure

Splice Variants

Pathogenic Mechanisms in Alzheimer's Disease

APP Processing and Trafficking

Synaptic Dysfunction

Therapeutic Implications

Small Molecule Modulators

Gene Therapy Approaches

Interaction Network

Animal Models

Knockout Mice

Transgenic Models

Clinical Studies

Genetic Associations

Biomarker Potential

Research Directions

References

Pathway Diagram

💬 Discussion

📗 Cite This Artifact

SORCS1 Gene

SORCS1 (Sortilin-Related VPS10 Domain Containing Receptor 1)

Overview

SORCS1 (Sortilin-Related VPS10 Domain Containing Receptor 1)

Overview

Function

Disease Associations

Alzheimer's Disease

Type 2 Diabetes

Parkinson's Disease

Expression

Mouse Models

Knockout Studies

Transgenic Overexpression

Phenotype Variations

Clinical Associations

Genetic Testing

Variant Interpretation

Genetic Counseling

See Also

External Links

Protein Structure

Splice Variants

Pathogenic Mechanisms in Alzheimer's Disease

APP Processing and Trafficking

Synaptic Dysfunction

Therapeutic Implications

Small Molecule Modulators

Gene Therapy Approaches

Interaction Network

Animal Models

Knockout Mice

Transgenic Models

Clinical Studies

Genetic Associations

Biomarker Potential

Research Directions

References

Pathway Diagram

💬 Discussion